Title: Endometriosis Market
1Endometriosis Market To Reach USD 2.42 Billion By
2026
2Increasing awareness about women's health,
increasing occurrence rate of the condition, the
rising focus on clinical trials are some of the
factors boosting the endometriosis market.
Market Size USD 1.93 Billion in 2018, Market
Growth - CAGR of 2.8, Market Trends The
increasing focus on clinical trial.The Global
endometriosis market is forecast to reach USD
2.42 Billion by 2026, according to a new report
by Reports and Data. Endometriosis is the
resultant of the growth of endometrial tissue on
bowel, ovaries, and tissues lining the pelvis.
The hormonal changes associated with the
menstrual cycle impacts the misplaced endometrial
tissue that results in the area to become
inflamed that causes pain. It implies that the
tissue will thicken, grow, and break down. With
time, the tissue that broken down has nowhere to
go and becomes trapped in pelvis.
Market Summary
www.reportsanddata.com
3- Further key findings from the report suggest
- In regards to the End-users, the Drugstores
segment can be seen to occupy the largest market
share of 30.2 in 2018, with the second-highest
growth rate of 3.1 during the forecast period.
The fact that in most cases of endometriosis,
pain in the primary issue, in which medication is
the first choice, has resulted in high dependency
on drugstores for availing the prescribed
medication, which contributes to the market share
occupied by this segment. - The endometriosis market held a market share of
USD 1.93 Billion in the year 2018 and forecasted
to grow at a rate of 2.8 during the forecast
period. - In regards to Drug Type, the NSAIDs segment
generated the highest revenue of USD 0.58 Billion
in 2018, with a growth rate of 2.9 during the
forecast period. The effectiveness of the
medicine in relieving pain caused by the
condition, which are nonsteroidal
anti-inflammatory drugs that work by
discontinuing the release of prostaglandins that
is one of the main chemicals resulting in the
pain, contributes to the revenue generated by the
NSAIDs segment. - In context to Surgery Type, the Laparoscopy
segment yielded the highest revenue of USD 0.87
Billion in 2018, with the fastest growth rate of
3.2 during the forecast period. The
effectiveness of this surgery in accurately
diagnosing endometriosis and even eliminate it in
mild-moderate condition with just a small
incision resulted in its increased demand and
revenue generated by the
4 Market Summary
- Key Players
- Johnson Johnson Services Inc., Bayer AG,
Neurocrine Biosciences Inc., Meditrina
Pharmaceuticals Inc., AbbVie Inc., Astellas
Pharma Inc., AstraZeneca Plc, Evotec AG,
Debiopharm Group and Teva Pharmaceutical
Industries Ltd. - Segmentation
- For the purpose of this report, Reports and Data
have segmented the global endometriosis market
based on Surgery Type, Drug Type, End-Users, and
region - Surgery Type Outlook (Revenue, USD Billion
2016-2026) - Laparoscopy
- Laparotomy
- Pelvic nerves surgery
- Drug Type Outlook (Revenue, USD Billion
2016-2026) - NSAIDs
- Gonadotropins Releasing Hormone Agonists
- Progestin
- Oral Contraceptive Pills
To look at the PDF Sample Report and get 30
minutes of a free consultation _at_
https//www.reportsanddata.com/sample-enquiry-form
/2553
www.reportsanddata.com
5 Market Summary
- End-Users Type Outlook (Revenue, USD Billion
2016-2026) - Hospital
- Pharmacies
- Drugstores
- E-commerce
- Regional Outlook (Revenue, USD Billion
2016-2026) - North America
- Europe
- Asia Pacific
- MEA
- Latin America
View press release for more information _at_
https//www.globenewswire.com/news-release/2020/03
/05/1996125/0/en/Endometriosis-Market-To-Reach-USD
-2-42-Billion-By-2026-Reports-And-Data.html
www.reportsanddata.com
6 The report emphasizes the following key
questions
Q.1.What are the most lucrative and promising
growth prospects for the market? Q.2.Which
sectors are expected to deliver a high growth
rate and which industry aspects come into play in
this advancement? Q.3.Which geographies are
estimated to exhibit the highest growth and the
underlying causes? Q.4.Which factors are
impacting the future of the market and what are
the driving factors? Q.5.What are the hurdles
and challenges curtailing the industrys growth
in the forecast period?
www.reportsanddata.com
7About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer market
intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise.
Contact Us John Watson Head of Business
Development Reports And Data Web
www.reportsanddata.com Direct Line
1-212-710-1370 E-mail sales_at_reportsanddata.com